Showing results (11-20 of 37) with videos related to
Sort By:
Pageof 4
Thrombosis Research|February 27, 2023
Trends and factors associated with outpatient anticoagulant treatment initiation among VTE patients with active cancerAmol D Dhamane, Shrushti Shah, Virginia Noxon, et al.Hospital Practice (1995)|July 29, 2020
Clinical characteristics and treatment patterns of patients with venous thromboembolism (VTE) transitioning from hospital to post-discharge settingsTanya Burton, Patrick Hlavacek, Jennifer D Guo, et al.Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|July 15, 2026
Trajectory of Kidney Function in T1D over Time: A Scoping ReviewFavian Co, Reid Whitlock, Arvind Katta, et al.Journal of Evidence-Based Medicine|June 20, 2019
An evaluation of WHO emergency guidelines for Zika virus diseaseSusan L Norris, Henry Louis, Veronica I Sawin, et al.Advances in Therapy|December 17, 2022
Effectiveness and Safety of Direct Oral Anticoagulants Among Patients with Non-valvular Atrial Fibrillation and MultimorbidityAmol D Dhamane, Mauricio Ferri, Allison Keshishian, et al.Journal of Thrombosis and Thrombolysis|August 2, 2023
Temporal trends in anticoagulation use and clinical outcomes among medicare beneficiaries with non-valvular atrial fibrillationBrett D Atwater, Jennifer D Guo, Allison Keshishian, et al.Thrombosis Research|December 21, 2020
Safety and effectiveness of apixaban compared with warfarin among clinically-relevant subgroups of venous thromboembolism patients in the United States Medicare populationJennifer D Guo, Patrick Hlavacek, Lisa Rosenblatt, et al.Current Medical Research and Opinion|August 24, 2022
Impact of apixaban treatment discontinuation on the risk of hospitalization among patients with nonvalvular atrial fibrillation and COVID-19Steven Deitelzweig, Julia Zhu, Jenny Jiang, et al.Journal of Thrombosis and Thrombolysis|August 2, 2023
Geographic variation in clinical outcomes and anticoagulation among medicare beneficiaries with non-valvular atrial fibrillationBrett D Atwater, Manuela Di Fusco, Allison Keshishian, et al.Current Medical Research and Opinion|August 8, 2019
Safety, effectiveness, and health care cost comparisons among elderly patients with venous thromboembolism prescribed warfarin or apixaban in the United States Medicare populationPatrick Hlavacek, Jennifer D Guo, Lisa Rosenblatt, et al.Pageof 4